seekingalpha.com
/1 month ago
Latest updates for Srpt
Fresh curated links around SRPT are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Sarepta: A Prove-It Story Now Defined By ELEVIDYS Execution
- Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy
- Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mecha
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy
qchron.com
/3 weeks ago
Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mecha...
First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a mo...
biopharmadive.com
/1 month ago
Scholar Rock SMA drug approved by FDA
Projected by some analysts as a future blockbuster, Isembyld is the first “muscle-targeted” treatment for the disease and, in clinical testing, helped improve motor function in peo...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Srpt
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source
qchron.com
Recent coverage from public sources
Public source